A universal fluorescence-based toolkit for real-time quantification of DNA and RNA nuclease activity by Sheppard, Emily C et al.
A universal fluorescence-based toolkit for real-time quantification 
of DNA and RNA nuclease activity 
 
  
  
Emily C. Sheppard1*, Sally Rogers1*, Nicholas J. Harmer1 and Richard Chahwan1,2 #  
  
  
  
1 Living Systems Institute, University of Exeter, Stocker Road, Exeter EX4 4QD, UK  
2 Institute of Experimental Immunology, University of Zurich, 8057 Zurich, CH  
 
 
  
 
  
* Authors contributed equally to this work 
# Corresponding author: Richard Chahwan (richard.chahwan@uzh.ch) 
  
 
 
 
 Word count: 5465 
  
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/548628doi: bioRxiv preprint first posted online Feb. 13, 2019; 
Abstract  
DNA and RNA nucleases play a critical role in a growing number of cellular processes ranging 
from DNA repair to immune surveillance. Nevertheless, many nucleases have unknown or 
poorly characterized activities. Elucidating nuclease substrate specificities and co-factors can 
support a more definitive understanding of cellular mechanisms in physiology and disease. 
Using fluorescence-based methods, we present a quick, safe, cost-effective, and real-time 
versatile nuclease assay, which uniquely studies nuclease enzyme kinetics. In conjunction 
with a substrate library we can now analyse nuclease catalytic rates, directionality, and 
substrate preferences. The assay is sensitive enough to detect kinetics of repair enzymes 
when confronted with DNA mismatches or DNA methylation sites. We have also extended our 
analysis to study the kinetics of human single-strand DNA nuclease TREX2, DNA 
polymerases, RNA, and RNA:DNA nucleases. These nucleases are involved in DNA repair, 
immune regulation, and have been associated with various diseases, including cancer and 
immune disorders.   
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Introduction  
DNA and RNA nucleases are a hallmark of a growing number of cell signalling cascades 
including the DNA damage response and immune diversification. They dictate many DNA 
repair pathway choices by controlling the DNA damage substrates created that dictate 
downstream options during the signalling cascade. The complex roles DNA and RNA 
nucleases play in DNA repair pathways underpin several premature ageing-, immune-, and 
tumour- related syndromes. All of which can result from aberrations in the structural and/or 
catalytic functions of DNA and RNA nucleases (reviewed in (1) and (2)). Despite their 
importance, the activities of numerous human DNA nucleases are still debated (e.g. Mre11, 
CTIP, etc. (3, 4)). There are also several yet uncharacterised proteins harbouring predicted 
nuclease domains in mammalian genomes (5–8).  
 
Even with their myriad and complex functions, DNA/RNA nucleases can be broadly defined 
by their substrate specificity, directionality of resection, and processivity. A significant 
restrictive limitation in nuclease studies has been the adequate identification of their catalytic 
functions and/or their relative activities against differing DNA/RNA intermediates. 
Conventional nuclease assays predominantly involve the use of radioactive labelling to 
visualise DNA substrates on an agarose gel (9–11). The use of radioactive isotopes delivers 
highly specific, sensitive assays that are free from interference. However, these assays are 
often inefficient, time-consuming, qualitative, and potentially hazardous (12, 13). Additionally, 
the assays are discontinuous, and must be stopped at discreet, often arbitrary, time points 
before measuring readouts (14). Whilst this can provide an indication of reaction rate, it does 
not allow for real-time visualisation of the catalytic resection activity.  
 
Radiolabelled oligonucleotides are gradually being replaced with fluorescent nucleic acid 
stains such as DAPI (15) and other commercially-available dyes including, but not limited to, 
Midori Green, SYBR Green I and Acridine Orange (16). PicoGreen (PG) is a commercially 
available dye that emits a fluorescent signal upon intercalation with double-stranded DNA 
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(dsDNA), emitting a fluorescent signal 1,000-fold stronger compared to when it is free in 
solution. In comparison, the Quant-It (QI) mircoRNA assay dye can specifically recognise 
short RNAs (<40-nts) and other nucleic acids. The superior sensitivity can quantify picogram 
or nanogram levels of dsDNA, respectively, unlike other fluorescent dyes, including Hoechst 
(17), ethidium bromide (17), EvaGreen (18), SYBR Green (18) and YOYO-1 (18). Several 
other sophisticated fluorescent techniques have been devised, building upon the use of 
FRET, whereby fluorescence is either quenched or dequenched following nuclease activity 
(19). Methods involving graphene oxide surfaces (20), electrochemical redox reactions (21–
23), complexing of DNA with a polycationic polymer (24), or immobilising nucleotides on 
magnetic beads (25) have also been developed. While highly sensitive, these methods have 
been designed purely for the detection of a very limited number of DNA and RNA nucleases 
rather than for their characterisation (26). 
 
Similar to other nucleic acid dyes, PG has proven to be a versatile DNA stain in different 
experimental conditions. PG has been used to visualise dsDNA in agarose electrophoresis 
as a quality control marker to identify fragmented and nicked DNA (27). It has also been 
implemented in flow cytometry analysis of cell-free DNA which can increase in certain 
pathologies, such as cancer and autoimmune syndromes (28). PG exhibits readily 
detectable, albeit reduced, fluorescence readings at temperatures of 37°C, despite 
manufacturer recommendations to work at room temperature (29). As PG very preferentially 
binds dsDNA compared to ssDNA and RNA structures (30), it has been an important feature 
of discontinuous enzyme-mediated DNA-modifying studies, such as nucleases (31), 
helicases (32), polymerases (33, 34), polymerase inhibitors (35), telomerases (36), and 
primases (37). However, the full potential of PG and QI in real-time visualisation of reaction 
progression remains limited (38).  
 
Here, we propose a PG and QI fluorescence-based toolkit for performing real-time 
fluorescent nuclease assays. Our toolkit has been optimised for a range of important 
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representative nucleases, including: DNase I (a non-specific nuclease), T7 exonuclease (a 
5’-3’ bacteriophage nuclease) (14), Exonuclease III (a 3’-5’ E. coli nuclease) (39), human 
Trex2 (a 3’-5’ ssDNA nuclease) (40), a viral nickase, Nt.CviPII (41), RNase A (a ssRNA 
nuclease) and RNase H (targets RNA in RNA:DNA hybrids). Furthermore, we designed a 
library of nucleotide substrates to account for these enzymes’ differential activities. Our DNA 
substrates are designed with biotin-TEG-modified 3’ or 5’ termini to provide insight into 
enzyme directionality. The addition of streptavidin to the biotinylated ends protects the 
substrate from resection at the modified end, as was demonstrated in a previous resection 
assay (10). This oligonucleotide library can be used to study a multitude of uncharacterised 
nucleases, and their substrate preferences, to elucidate their roles in DNA repair and 
genomic maintenance. To extend the power of our approach, we have designed 
physiologically relevant substrates containing mismatches and methyl-cytosines. It has been 
posited that repair nucleases resect along a methylated sequence of DNA, thus permanently 
removing epigenetic markers. Upon recognition of a mismatch, the mismatch repair (MMR) 
machinery generates incisions either side of the error, allowing the 5’-3’ exonuclease Exo I 
to resect through the mismatch, permitting polymerases to accurately replicate across the 
resulting ssDNA tract (42). As such, it would be interesting to determine whether this 
mismatch is permissive to nucleases in general. 
 
Our assay relies on the loss or gain of the DNA duplex structure, and so is potentially useful 
for study of other enzymes that reconstitute or compromise the DNA-pairing structure. As an 
example, we demonstrate the observation of polymerase activity by monitoring an increase 
in fluorescence as the complementary strand is synthesised by the nuclease-deficient 
Klenow fragment DNA polymerase. PG has previously been used to visualise polymerase 
activity, but to our knowledge, this is the first time it has been described in a real-time, 
continuous assay (33). Our work provides a robust and versatile universal toolkit to 
characterise both DNA and RNA nucleases, and determine their substrate preferences with 
high resolution and sensitivity. This assay can be adapted and modified to suit a wide range 
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of DNA repair applications. This fluorescence-based method is faster, cheaper, and safer 
than conventional DNA/RNA resection assays using radioisotopes. Additionally, it works 
cross-species and is platform agnostic. Furthermore, this protocol is sensitive enough for 
enzyme reaction kinetic calculations and can distinguish the structural preferences exhibited 
by an enzyme for its substrate.  
 
Materials and Methods 
Oligonucleotides 
DNA substrates were prepared by diluting plasmid DNA in HyClone waterTM (GE 
healthcare), and unmodified HPLC-purified oligonucleotide substrates (Eurofins) and 
modified HPLC-purified oligonucleotides (Integrated DNA Technologies) in 1X Annealing 
Buffer (Sigma-Aldrich) for DNA substrates and siMAXTM dilution buffer (Eurofins) for all RNA 
substrates. Oligonucleotides were designed and optimised against secondary structure 
formation using the ‘Predict a Secondary Structure Web Server’ 
(https://rna.urmc.rochester.edu/RNAstructureWeb/Servers/Predict1/Predict1.html)(43) and 
annealed at a 1:1 molar ratio. Table 1 shows all the oligonucleotides and their respective 
illustrations, while Table S1 lists the olignonucleotide sequences and modifications.  
 
Nucleases and PG preparation 
The nucleases used were RQ1 RNase-Free DNase I (Promega), T7 exonuclease (New 
England Biolabs), Exonuclease III (New England Biolabs), Trex2 (Stratech), Klenow 
Fragment (3’ Æ 5’ exo-; New England Biolabs) , RNase A (Thermo Fisher) and RNase H 
(New England Biolabs). In preparation for each assay, nucleases used were diluted on ice in 
their appropriate storage buffers, omitting glycerol. DNase I, T7 exonuclease, Exonuclease 
III, Trex2 and Klenow fragment storage buffers and reaction buffers were all filtered prior to 
use, and autoclaved where possible.  
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The PG reagent from the Quant-iTTM PicoGreenTM dsDNA Assay Kit (Invitrogen) was 
prepared immediately before use by making a 1:200 dilution of the PG in TE buffer (10 mM 
Tris-HCl, 1 mM EDTA, pH 7.5) and 40% (v/v) glycerol.  For the RNase assays, the dye from 
the Quant-iTTM microRNA Assay Kit (Invitrogen) was prepared by diluting the microRNA 
reagent A into buffer B in a 1/2000 dilution, as detailed in the protocol for the kit. 
 
Experimental procedure 
Each DNA substrate reaction mixture contained 50 nM DNA substrate, 1X reaction buffer 
(specific for each enzyme), 50 µL PG solution, 0.02 mg/mL streptavidin (cat. 21125, Thermo 
Fisher Scientific) if required, 0.25 mM dNTPs if required, 5 µL enzyme or relevant storage 
buffer. For the DNA nucleases, Milli-Q water was added to bring the total reaction volume to 
100 µL. The RNA nuclease reaction mixtures,  contained 50 nM RNA substrate 90 µL 
Quant-iT reagent and 5 µL enzyme or relevant storage buffer. RNase A does not require a 
specific reaction buffer for its activity, and therefore the enzyme was instead diluted in TE 
buffer. RNase-free HyClone™ Water (cat. SH305380, Fisher Scientific) was used to bring 
the reaction volume to 100 µL,. Samples were tested in a 96-well, black flat bottom plate 
(cat. M9685, Sigma-Aldrich). The final components added were the storage buffers, then the 
enzyme mixtures, in order to start the reaction.  
All storage buffers and reaction buffers were made according to the recipes available on 
their respective NEB and Thermo Fisher web pages.  
A CLARIOstar microplate reader (BMG labtech) was pre-heated to 37°C. Samples were 
read every 40-50 s for 30-60 mins. Excitation and emission wavelengths used were 483-15 
nm and 530-30 nm, with a focal height of 10.2, 20 flashes per well, with a shake before each 
read.   
 
Data analysis 
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For statistical analysis of the data, one-way ANOVA with the Tukey’s post-hoc tests were 
used. This was implemented using GraphPad Prism v7.03. An example of the workflow is 
available in Supplementary Materials.  
 
Results 
Establishing assay parameters using DNase I 
The foundation of the nuclease assay reported here is to monitor the corresponding loss of 
the fluorescent signal as dsDNA is degraded in response to DNA metabolizing enzymes, 
primarily DNA nuclease activities. As illustrated (Fig.1a), PG binds to dsDNA and produces a 
fluorescent signal that is approximately 400-fold more intense compared to when it is free in 
solution. Upon the addition of a nuclease, such as DNase I, the duplex structure is lost as 
the enzyme digests the DNA.  
 
A calibration curve was established to determine the linear range in which the concentration 
of DNA is directly proportional to the fluorescent signal (Fig. 1b). We compared both plasmid 
DNA (13.1 kb) and oligonucleotide DNA (80 bp) and determined that the maximum 
concentration of DNA that could be used in the assay was 2.5 ng/µL regardless of the length 
and structure of the DNA. Above 2.5 ng/µL this, the fluorescent signal plateaued irrespective 
of the increase in DNA concentration (Fig. 1b).  
 
As an alternative to converting fluorescence to molar concentrations, which vary according 
to the length of the DNA substrate (Fig. S1a-d), we generated a standard curve based on the 
signal produced from 80-, 60-, 40- and 20-bp substrates, as well as a 0-bp single-stranded 
80-mer oligomer to represent the final resection product of other resection nucleases 
(Fig.1c). PG binds ssDNA with a lower affinity than dsDNA, as indicated by the standard 
curve. For resection nucleases (Fig. 2 and 3) as opposed to DNase, this is a more 
appropriate end-point of the reaction rather than the comparatively minor fluorescent signal 
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produced in the absence of substrate. This standard curve shows a linear increase in 
fluorescence with the length of duplex DNA (R2 = 0.99).  
 
The purpose of the standard curve is to enable the conversion of fluorescence units to DNA 
base pairs to calculate the length of substrate remaining following nucleolytic attack. To 
convert the data from fluorescence units, the data is first normalised to their relevant control 
(absence of enzyme). This has the additional benefit of accurately accounting for the 
inevitable photobleaching effect. As such, any decrease in fluorescence recorded is a result 
of nuclease activity and not photobleaching of the PG. We then convert the standard curve 
to base pairs by finding the gradient (m) and intercept (c) of the curve at each time point, and 
from this we can determine the length of dsDNA (x-axis) from the fluorescent signal (y-axis) 
at each time point and experimental condition. A worked example is available in 
Supplementary Materials.  
 
We performed a DNase I titration and converted the y-axis from fluorescence units to length 
of dsDNA (Fig. 1d). From this we determined that the rate increases with the concentration 
of DNase I, therefore indicating that the reaction is first order with respect to the enzyme 
(Fig. 1e). We then calculated that the rate of digestion mediated by DNase I on a 2.5 ng/µL 
80-bp dsDNA substrate at 37°C is approximately 0.001 bp nM-1 sec-1 (Fig. 1f).  
 
Optimisations for substrate-specific nucleases 
3’-5’ nucleases: Exonuclease III 
Oligonucleotides are far more versatile substrates than plasmids as they can be designed to 
have different terminal structures, such as 5’ or 3’ overhangs, Y-structures, Holliday 
junctions, strand invasion or even G-quadruplexes (44). Their much shorter length ensures 
that each enzyme is confronted with a higher proportion of these alternative structures. As 
such, only oligonucleotides were used for further development of the assay. Our 
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oligonucleotides were designed and optimised so as to reduce the likelihood of secondary 
structure formation in the ssDNA (43).  
 
To account for having a sufficient dsDNA region as well as structurally appropriate terminal 
ends to study nuclease structural preferences, we designed substrates that were blocked at 
one end in order to direct the enzyme to resect one single strand only, leaving a full-length, 
blocked, single-stranded 80-mer substrate as the end product. The substrates were blocked 
with biotin-TEG (BITEG) at the necessary terminal ends. BITEG alone is insufficient to inhibit 
resection on substrates blocked at both terminal ends. However, inclusion of streptavidin in 
the reaction mix successfully protected the modified ends from resection (Fig. S2a-b). We 
noticed that the presence of streptavidin, but not BITEG alone, is responsible for preventing 
total resection, prohibiting ExoIII from resecting the final 20 nucleotides (Fig. S2c). This 
combination of biotin and streptavidin has previously been shown to be effective (10).  
Substrates blocked at both ends while in the presence of streptavidin and treated with 
enzyme show 15-20% loss of fluorescence. The expected purity of the oligomers 
synthesised is approximately 85% and, as such, there is always a small proportion of 
substrate present that either lacks the BITEG modification, or is not synthesised to full-
length, rendering them susceptible to resection (Fig. S2a-c). One additional benefit of using 
BITEG and streptavidin to block resection is that it does not require prior knowledge of 
inhibitory structures (e.g. designing  4-nt 3’-overhangs to inhibit ExoIII (45) or a 22-nt 5’-
overhang specifically to inhibit T7 Exo (14)).  
 
We ensured that the linear range is maintained with the addition of BITEG and streptavidin 
using a calibration curve (Fig. 2b). While the overall fluorescence is lower, the maximal 
usable concentration of substrate remains unchanged. We then tested whether the assay 
could be used to study the activity and structural preference of 3’-5’ exonucleases, such as 
ExoIII. ExoIII has been well-characterised, and so we attempted to replicate its known 
activities in our assay. A range of ExoIII titrations were performed on three different 
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substrates: blunt ended, 2-nt 3’-overhang, and a 4-nt 3’-overhang. The substrates have been 
depicted as cartoons for simplicity, and have been named according to their modifications; 
for example, S* indicates a 3’-terminal BITEG modification, and +2S* indicates a 3’-BITEG 
modification, and a 2-nt 3’ overhang on the opposite strand. *S would instead reference a 5’-
BITEG modification. The preference of ExoIII for blunt and 2-nt overhangs is known, as well 
as the inhibitory effect of 4-nt 3’-extensions, as these activities are often exploited for various 
sequencing and DNA detection techniques (46–49) (Fig. 2c-e). After determining the rate of 
resection on all substrates (Fig. 2f-g), it is clear that this assay is readily able to detect the 
previously reported substrate specificity of ExoIII. ExoIII is completely inhibited by 4-nt 3’-
overhangs, and resects with this with a similarly low rate as the negative control, which has 
both 3’-ends blocked with BITEG and streptavidin. There is a peak of activity at 10 nM 
ExoIII, in which the rate of resection appears to be twice as efficient compared to higher and 
lower concentrations of the enzyme.  
 
Through analysis of the efficiency of each nuclease, we can also compare the activities of 
ExoIII and DNase I. These results suggest that the ExoIII resection activity is approximately 
five-fold faster than the DNase I nuclease activity (Fig. 2g) at 37°C in their respective 
buffers.   
 
5’-3’ exonuclease: T7 exonuclease 
Having demonstrated that this assay is suitable for 3’-5’ nucleases, we next explored 
whether the assay could be used to study 5’-3’ nucleases. This necessitated the synthesis of 
substrates presenting 5’-BITEG modifications. We tested the affinity of T7 Exo for a selection 
of substrates, incorporating blunt, 2-, 10- and 20-nt 5’-overhangs (Fig. 3a). T7 Exo shows no 
significant difference between the affinity for blunt and 2’-nt 5’-overhangs. As had previously 
been observed, the rate of T7 Exo-mediated resection with a 20-nt overhang was 
approximately 50% of a short overhang (14) (Fig. 3b). Unexpectedly, as the length of the 
overhang increased, resection was slightly delayed. However, after resection commenced, it 
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appeared to take place at a faster rate on the intermediate overhangs, considering that the 
reaction culminates at approximately the same time point on all substrates (p<0.002 
between *S and *S+10, and p<0.0001 between *S and *S+20) (Fig. 3b). Regardless, difference 
in rate is rather minimal. In contrast to ExoIII, T7 Exo is limited, but not inhibited, by the 20-nt 
overhang. 
 
Studying enzyme resection through single-nucleotide mismatches  
During mismatch repair, DNA nucleases resect through the mismatch to generate a single-
stranded tract of DNA along which DNA polymerases can replicate (50–54). It has been 
suggested that these resection events may even remove epigenetic signatures on the DNA, 
such as 5-methylcytosine (55), which may then be permanently lost when repaired with an 
unmodified cytosine, and not targeted by de novo methyltransferases, Dnmt3a or Dnmt3b 
(56, 57). We therefore tested if our assay can detect differences in resection rates through 
mismatched and methylated substrates. 
 
We investigated ExoIII activity on mismatched substrates compared to matching substrates 
and identified some unexpected activities. First, we observed that ExoIII resects the two 
perfectly matching substrates at substantially different rates, resecting *S at a 1.7 – 2.0-fold 
faster rate than S* (Fig. 4a-d) *SC>T contains a selection of C>T substitutions, whilst G>AS* 
contains G>A substitutions, generating T:G and A:C mismatches, respectively. The 
presence of the T:G mismatches slows the rate of resection 0.09 – 0.16X compared to its 
perfectly matching counterpart (p<0.001 for 5 nM ExoII; p<0.05 for 10 nM ExoIII; Fig 4d). 
Conversely, incorporating A:C mismatches increases the rate of resection by 1.5 – 1.8X 
(p<0.0001 with both 5 and 10 nM ExoIII). There is some evidence for a nucleotide 
preference for ExoIII, although this has not been repeated to the best of our knowledge (58). 
The rate of resection on both the perfectly matching substrate appears to have a delayed 
start, particularly for S*. Interestingly, *S is then resected at an accelerated rate compared to 
both mismatched substrates. The mismatches resect at a slower rate but, as their resection 
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begins at the offset, the reaction on the mismatched substrates and *S finish at the same 
time point for both 5 and 10 nM ExoIII.  
 
T7 exonuclease is considered to be sequence-independent as it lacks a defined DNA 
binding-motif, similar to other FEN family nucleases that bind DNA in a nonspecific manner 
(14, 59). Nevertheless, it has previously been suggested that it might resect different 
nucleotides with variable efficiency (60). Indeed, we observed that T7 Exo resects the 
perfectly complementary *S with more difficulty than S*, which was noticeable at higher 
concentrations of T7 Exo (Fig. 4e-g). Similarly with T7 Exo, our assay detected a substrate 
strand preference (Fig. 4h).  
 
The addition of four T:G mismatches did not slow or accelerate T7 Exo activity. However, 
incorporating A:C mismatches into the more resistant substrate did appear to slow resection, 
and this general trend was observed across all concentrations of T7 Exo. The effect of the 
mismatches was more evident at lower T7 Exo concentrations (p<0.05 for 7.5 nM and 
p<0.01 for 2 nM T7 Exo). These data suggest that mismatches may only be inhibitory to T7 
Exo in certain sequence contexts. Indeed, T7 Exo has been shown to recognise single-
nucleotide mismatches in an SNP-detection system (61).  
 
Enzyme resection through methylated cytosines  
Neither ExoIII nor T7 Exo is substantially inhibited by methylated DNA in this experimental 
system. At the lower concentration of ExoIII, we see a delay in resection initiation (Fig. 5a), 
resulting in staggered end points (Fig. 5c). However, once ExoIII starts to resect, the rates 
are not significantly different between the methylated and non-methylated substrates (Fig. 
5d). This delay in resection is not observed at higher concentrations of ExoIII (Fig. 5b). T7 
Exo showed no significant effect on either maximum rate or time taken to resect in the 
presence of methylated cytosines (Fig. 5e-h). To our knowledge, there is no data on the 
effect of methylcytosine on either ExoIII or T7 Exo resection with which to compare.  
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 Validation of nuclease activity assay on nicks and gaps, and its use in studying 
nickases in combination with processive nucleases 
Nicks and gaps are introduced as intermediates in DNA repair mechanisms, yet they need to 
be rapidly processed to prevent the accretion of double-strand breaks at replication forks, 
possibly leading to cell death (10, 62).  
 
Due to the physiological relevance of nicks and gaps, we explored the nucleolytic activity of 
ExoIII and T7 Exo on these structures. In order to test this, we used a combination of 
substrates that had been designed to contain a nick or gap, in conjunction with blocking at 
both ends (both 5’ or 3’, respectively) to prevent resection from the terminal ends. We also 
included a recently-purified nickase, Nt.CviPII (41) which is known to possess inherent 
exonuclease activity. Nickases cleave just one strand of duplex DNA, breaking the 
phosphodiester backbone. Nt.CviPII preferentially cuts CCA and CCG, but cuts less 
efficiently at CCT (41). One strand of the dsDNA substrate contains five evenly distributed 
CCA motifs, while the opposite strand only contains two CCT motifs, and therefore most of 
ExoIII’s activity should be directed on the first strand (Fig. 6a). To minimise the exonuclease 
activity of Nt.CviPII, we used a low dilution of the nickase. 
 
Our results show that ExoIII functions marginally better on gaps rather than nicks (p<0.0001) 
(Fig. 6d and 6f), and this may reflect its role in base excision repair where it resects from an 
abasic site (39). ExoIII is nevertheless able to resect from a nick, and the rate is comparable 
to its activity on blunt ends, as previously observed (63). ExoIII also resected from the 
nickase-induced nicks at an almost equal rate to the substrates designed to contain a single 
nick (Fig. 6e and 6f). These data demonstrate that Nt.CviPII is a very fast acting nickase 
against its preferred substrate sequences as there is no delay in the start of ExoIII-mediated 
resection.  
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As with ExoIII, T7 Exo also resects from both nicks and gaps. It has a more defined 
preference for gaps, showing a rate approximately 2.5-fold greater than for nicks (p<0.0001; 
Fig. 6g and 6i). T7 Exo also resects from nicks generated by a nickase almost as efficiently 
as from a substrate already presenting a single nick (Fig. 6h and 6i). Typically, T7 
endonuclease cleaves at nicked sites during infection to generate DNA double-stranded 
breaks that are susceptible to T7 Exo. As such, it is perhaps a redundant property of T7 Exo 
to resect from a nick (64). 
 
Alternative enzymes that degrade or synthesise dsDNA can be studied 
We have demonstrated that PG is an effective dye that can be used to study dsDNA 
nucleases from viruses and bacteria. Given the low, but not insignificant, fluorescent signal 
observed for the single-stranded 80-mer control in the standard curves, we reasoned that 
this assay may have the sensitivity to address ssDNA nucleases, such as human Trex2 (65). 
We confirmed this by showing that the assay is sensitive enough to detect a Trex2 
concentration-dependent decrease in fluorescence from ssDNA substrates ranging in size 
from 60 to 20 nts (Fig.7a). This indicates that this assay has considerable potential for an 
even wider range of DNA nucleases, and very high levels of sensitivity in order to capture 
such activity in detail. As expected, it takes longer for Trex2 to digest longer substrates (Fig. 
7b). In terms of reaction kinetics, rate of resection is generally consistent, ranging between 
1.7 x 10-4 – 3.4 x 10-4 nt nM-1 sec-1 (Fig. 7c), which is comparable to previously published 
rates (66). 
 
Since we have shown that this assay is a powerful tool for observing nuclease activity, we 
attempted to study whether we could capture the reverse activity and visualise an increase 
in fluorescence upon addition of polymerase. To investigate this, we employed the use of the 
well-characterised Klenow fragment polymerase (KF). KF requires a short DNA primer 
fragment hybridised to a ssDNA fragment along which it can replicate. We used a selection 
of 80-mer oligomers hybridised to a 20-, 40-, 60- and 80-mer oligomer (Fig. 7d). The data 
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clearly indicate that KF-dependent blunting of the 20mer 5’-overhang is possible to visualise 
in the context of this real-time assay. KF appears to be unable to extend the 20- and 40-mer 
primers to produce the full-length 80 bp dsDNA product. KF-elongation of both are inhibited 
once the primers have been extended to 50- or 55-mer lengths (Fig. 7d). It is understood 
that KF is sensitive to secondary structures in the ssDNA template, and the presence of a 
small hairpin adjacent to this region may be responsible for inhibiting polymerisation past this 
point. Previously, a terminal hairpin has not inhibited KF processivity,  although an internal 
hairpin, such as in this case, may have a different impact on KF (67). Analysis of the rate of 
replication suggests a preference for a longer ssDNA template, as KF polymerises at a much 
faster rate on the 60mer 5’-overhang, while the 40- and 20-mer 5’-overhangs are processed 
at a three-fold lower rate (Fig. 7e). 
 
RNA and RNA:DNA nucleases can be also be analysed in real-time 
We have established a straightforward and robust assay that can measure DNA nuclease 
activity. To expand the potential of this assay to include RNA nucleases, we employed the 
use of an alternative RNA-sensitive fluorescent dye available in the Quanit-iT microRNA 
assay kit, as PG emits very low fluorescent signal in the presence of RNA.  
 
With the use of RNA nucleases, RNase A and RNase H, we ascertained that we could 
reproduce their known activities. Indeed, we observed that RNase A efficiently resected 
ssRNA (Fig. 8a), at a rate of approximately 180 nt nM-1 sec-1 on a 20-nt substrate, and 90 nt 
nM sec-1 on a 40-nt substrate (Fig. 8b). As expected, RNase A failed to show any nucleolytic 
activity on dsRNA, RNA:DNA hybrids, or dsDNA (Fig. S3a-c). Interestingly, in this buffer the 
20- and 40-mer RNA substrates emitted very similar fluorescent signals and could not be 
teased apart, yet the fluorescent signals were easily distinguishable on dsRNA and 
RNA:DNA hybrid substrates (Fig. S3a-b).  
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On the other hand, RNase H exerts a distributive cleavage pattern on the RNA substrate of 
RNA:DNA hybrids, periodically cleaving the RNA to produce fragments (Fig. 8c). RNase H 
did not show any affinity for ssRNA, dsRNA, or dsDNA substrates (Fig. S4a-c). This may 
account for the much slower rates exhibited by RNase H, as it digested the RNA component 
of RNA:DNA hybrid substrates at 2.0 x 10-5 nt nM-1 sec-1 on the 20-bp substrate, and 3.5 x 
10-5 nt nM-1 sec-1 on the 40-bp substrate (Fig. 8d).  
 
Discussion 
We have further developed a highly-sensitive, fluorescence-based universal nuclease assay 
that works in real-time and designed a library of substrates that are appropriate for 
investigating a wide range number of nucleases, polymerases, and helicases. This assay 
can be used to calculate reaction kinetics and reaction completion times, providing a 
powerful quantitative tool for characterising enzymes active on nucleic acids. We have 
successfully validated the technique using well-studied enzymes and, in the process, 
identified previously unreported details of their mechanisms.   
 
Our assay has important applications in comparing the relative activities of enzymes. Here, 
we identified that ExoIII hydrolyses the DNA substrate at a faster rate than DNase I in their 
respective buffers. DNase I exhibits a relatively low affinity for DNA, and higher affinity 
strains have been engineered for treatment of cystic fibrosis (68, 69). DNase I may have 
evolved to be less efficient due to the fact that it can digest all structures of DNA, irrespective 
of whether it is single- or double-stranded, and deregulation of this activity could be 
disastrous for the cell. This limitation in its binding may exert some control to prevent 
inappropriate activity from causing cellular damage. ExoIII shows a greater rate of resection 
per enzyme protomer, yet this is counteracted by its very limited structural specificity. The 
product of ExoIII resection during E. coli base excision repair is a single-stranded tract of 
DNA that can be much more easily repaired than the damage caused by DNase I (70, 71).   
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We were also able to compare substrate specificities, as indicated by the preference of 
ExoIII for 3’-overhangs shorter than 4-nt and T7 Exo’s predilection for 5’-overhangs of 10-nt 
or fewer. As T7 Exo typically resects DNA from short 5’-overhangs introduced by T7 
endonuclease during the infection process in E. coli, our results are consistent with its 
behaviour in vitro and in vivo (14, 64). In addition to substrate structures, we have 
considered other physiologically relevant substrates containing single-nucleotide 
mismatches and methylcytosines. Unexpectedly, we found that ExoIII and T7 Exo exhibited 
a preference for one strand of the DNA substrate. There is evidence of a nucleotide 
preference for ExoIII; C>A~T>G, although it seems that it depends on the sequence context 
(58). Nevertheless, the results of their mismatched counterparts do coincide with published 
ExoIII preferences (58). As such, this confirms previously reported preferences in both a 
qualitative and quantitative way. Work is continuing in our lab to understand the mechanisms 
of ExoIII, and so we hope to elucidate its nucleotide preferences thoroughly.  
 
For methylated substrates, we observed that resection is delayed for lower concentrations of 
ExoIII and are inhibited slightly by the presence of multiple methylcytosines. The rate of 
resection, however, remains consistent on all substrates. At higher concentrations, ExoIII 
does not appear to distinguish the methylcytosines. T7 Exo does not show any alteration in 
activity from the methyl groups. Its host, E. coli, contains a small percentage of methylated 
adenines and cytosines, and it appears that T7 Exo does not discriminate against them. This 
is in spite of a smaller percentage of methylated DNA ending up in the T7 bacteriophage’s 
progeny DNA than is present in the E. coli genome (72).  
 
While this assay is predominantly useful for studying processive enzymes, it is possible to 
combine a nickase with an enzyme that resects from nicks, as indicated with nickase 
Nt.CviPII in conjunction with either ExoIII or T7 Exo. This is a powerful method to identify 
nicking or endonuclease activities, and study their efficiency based on when resection 
commences.  
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 The superior sensitivity of PG in this assay also expanded our repertoire of enzymes to 
include ssDNA nucleases, such as Trex2. Trex2 is one of at least eight autonomous 
exonucleases in human cells, and is likely recruited to 3’-termini to alleviate blocks during 
replication arrest (73). It binds DNA very tightly, and this affinity for its substrate has been 
captured here due to its very rapid processivity. In addition to the study of enzymes that 
digest DNA, we extended our study to enzymes that polymerise DNA, such as the nuclease-
deficient Klenow fragment polymerase. Its polymerase activity is ten-fold more rapid, for 
example, than ExoIII at resection in their respective buffers 
 
We further explored the fluorescent dye QI which, unlike PG, recognises RNA 
polynucleotides. The activities of RNase A and H were captured in real-time, where we 
recapitulated their known activities on ssRNA and the RNA strand of RNA:DNA 
heteroduplexes, respectively.   
 
Characterisation of DNA nucleases is integral for demystifying their roles in maintenance of 
genomic integrity. Loss of nucleases, or mutations in their structural or functional domains, 
can have disastrous effects on the health of an organism. The impact of these mutations 
could affect resection rates or binding affinity to the DNA or interacting partners, and we 
posit that this assay may be sensitive enough to capture and compare these characteristics 
(69, 74, 75). Many nucleases have been well-characterised, including those used in the 
optimisation of this assay, while many more have yet to be characterised at all.  
 
Nucleases may also represent anticancer targets, and this assay could offer an alternative 
method for studying the effect of future anticancer drugs on the activity of their target 
nuclease (76). In a similar instance, a discontinuous assay using PG was successfully 
performed to study the inhibitory role of actin on DNase I (77). As such, this assay 
represents a safe, easy, rapid, robust, real-time study of dsDNA and ssDNA nucleases and 
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polymerases. We believe that it has the potential to revolutionise quantitative assessment of 
DNA and/or RNA cleaving enzymes in a vast range of applications.  
 
 
Additional information 
See attached supplementary information 
  
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/548628doi: bioRxiv preprint first posted online Feb. 13, 2019; 
 Acknowledgements and Funding 
We are grateful to Dr Mirella Vivoli (University of Florence) for her insight in the early 
development of this assay; and to Fulvia Bono (University of Exeter) for her insight on RNA 
nucleases and her support of this project. We are also very thankful to Adam Thomas 
(University of Exeter) for his knowledge and guidance on the data analysis. We also thank 
Matthew Scharff and Shanzhi Wang (Albert Einstein College of Medicine), and Michael 
Dillon (University of Exeter) for helpful suggestions. Funding for RC was provided by 
Biotechnology and Biological Research Council [BB/N017773/1], Royal Society [IE150290], 
and Academy of Medical Sciences [SBF001\1005]. ECS is funded by a PhD studentship 
from the Biotechnology and Biological Research Council-funded South West Doctoral 
Training Partnership [BB/J014400/1].  
 
Competing Interests 
The authors declare no competing interests.  
 
 
  
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/548628doi: bioRxiv preprint first posted online Feb. 13, 2019; 
References 
 
1. Bartosova,Z. and Krejci,L. (2014) Nucleases in homologous recombination as targets for 
cancer therapy. FEBS Lett., 588, 2446–2456. 
2. Rigby,R.E. and Rehwinkel,J. (2015) RNA degradation in antiviral immunity and 
autoimmunity. Trends Immunol., 36, 179–88. 
3. Paull,T.T. and Deshpande,R.A. (2014) The Mre11/Rad50/Nbs1 complex: recent insights 
into catalytic activities and ATP-driven conformational changes. Exp. Cell Res., 329, 
139–47. 
4. Makharashvili,N. and Paull,T.T. (2015) CtIP: A DNA damage response protein at the 
intersection of DNA metabolism. DNA Repair (Amst)., 32, 75–81. 
5. Kosinski,J., Feder,M. and Bujnicki,J.M. (2005) The PD-(D/E)XK superfamily revisited: 
identification of new members among proteins involved in DNA metabolism and 
functional predictions for domains of (hitherto) unknown function. BMC Bioinformatics, 
6, 172. 
6. Babbs,C., Roberts,N.A., Sanchez-Pulido,L., McGowan,S.J., Ahmed,M.R., Brown,J.M., 
Sabry,M.A., Bentley,D.R., McVean,G.A., Donnelly,P., et al. (2013) Homozygous 
mutations in a predicted endonuclease are a novel cause of congenital 
dyserythropoietic anemia type I. Haematologica, 98, 1383–1387. 
7. Silva,S., Homolka,D. and Pillai,R.S. (2017) Characterization of the mammalian RNA 
exonuclease 5/NEF-sp as a testis-specific nuclear 3’ → 5’ exoribonuclease. RNA, 23, 
1385–1392. 
8. Guan,R.-B., Li,H.-C., Fan,Y.-J., Hu,S.-R., Christiaens,O., Smagghe,G. and Miao,X.-X. 
(2018) A nuclease specific to lepidopteran insects suppresses RNAi. J. Biol. Chem., 
293, 6011–6021. 
9. Claeys Bouuaert,C. and Keeney,S. (2017) Distinct DNA-binding surfaces in the ATPase 
and linker domains of MutLγ determine its substrate specificities and exert separable 
functions in meiotic recombination and mismatch repair. PLOS Genet., 13, e1006722. 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/548628doi: bioRxiv preprint first posted online Feb. 13, 2019; 
10. Anand,R., Ranjha,L., Cannavo,E. and Cejka,P. (2016) Phosphorylated CtIP Functions as 
a Co-factor of the MRE11-RAD50-NBS1 Endonuclease in DNA End Resection. Mol. 
Cell, 64, 940–950. 
11. Nowotny,M., Gaidamakov,S.A., Crouch,R.J. and Yang,W. (2005) Crystal structures of 
RNase H bound to an RNA/DNA hybrid: substrate specificity and metal-dependent 
catalysis. Cell, 121, 1005–16. 
12. Wyatt,H.D.M., Laister,R.C., Martin,S.R., Arrowsmith,C.H. and West,S.C. (2017) The 
SMX DNA Repair Tri-nuclease. Mol. Cell, 65, 848–860.e11. 
13. Abdullah,U.B., McGouran,J.F., Brolih,S., Ptchelkine,D., El‐Sagheer,A.H., Brown,T. and 
McHugh,P.J. (2017) RPA activates the XPF‐ERCC1 endonuclease to initiate 
processing of DNA interstrand crosslinks. EMBO J., 36, 2047–2060. 
14. Mitsunobu,H., Zhu,B., Lee,S.-J., Tabor,S. and Richardson,C.C. (2014) Flap 
endonuclease activity of gene 6 exonuclease of bacteriophage T7. J. Biol. Chem., 289, 
5860–75. 
15. Buel,E. and Schwartz,M. (1995) The use of DAPI as a replacement for ethidium bromide 
in forensic DNA analysis. J. Forensic Sci., 40, 275–8. 
16. Schmidt,F., Schmidt,J., Riechers,A., Haase,S., Bosserhoff,A.-K., Heilmann,J. and 
König,B. (2010) DNA Staining in Agarose Gels with ZN 2+ -Cyclen-Pyrene. Nucleosides, 
Nucleotides and Nucleic Acids, 29, 748–759. 
17. Gallagher,S.R. (2017) Quantitation of DNA and RNA with Absorption and Fluorescence 
Spectroscopy. In Current Protocols in Immunology. John Wiley & Sons, Inc., Hoboken, 
NJ, USA, Vol. 116, p. A.3L.1-A.3L.14. 
18. Bruijns,B., Tiggelaar,R. and Gardeniers,H. (2017) Dataset of the absorption, emission 
and excitation spectra and fluorescence intensity graphs of fluorescent cyanine dyes for 
the quantification of low amounts of dsDNA. Data Br., 10, 132–143. 
19. Su,X., Zhang,C., Zhu,X., Fang,S., Weng,R., Xiao,X. and Zhao,M. (2013) Simultaneous 
Fluorescence Imaging of the Activities of DNases and 3′ Exonucleases in Living Cells 
with Chimeric Oligonucleotide Probes. Anal. Chem., 85, 9939–9946. 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/548628doi: bioRxiv preprint first posted online Feb. 13, 2019; 
20. Zhou,Z., Zhu,C., Ren,J. and Dong,S. (2012) A graphene-based real-time fluorescent 
assay of deoxyribonuclease I activity and inhibition. Anal. Chim. Acta, 740, 88–92. 
21. Sato,S., Fujita,K., Kanazawa,M., Mukumoto,K., Ohtsuka,K., Waki,M. and Takenaka,S. 
(2008) Electrochemical assay for deoxyribonuclease I activity. Anal. Biochem., 381, 
233–239. 
22. Hillier,S.C., Frost,C.G., Jenkins,A.T.A., Braven,H.T., Keay,R.W., Flower,S.E. and 
Clarkson,J.M. (2004) An electrochemical study of enzymatic oligonucleotide digestion. 
Bioelectrochemistry, 63, 307–310. 
23. Sato,S., Fujita,K., Kanazawa,M., Mukumoto,K., Ohtsuka,K. and Takenaka,S. (2009) 
Reliable ferrocenyloligonucleotide-immobilized electrodes and their application to 
electrochemical DNase I assay. Anal. Chim. Acta, 645, 30–35. 
24. Ding,J. and Qin,W. (2013) Potentiometric sensing of nuclease activities and oxidative 
damage of single-stranded DNA using a polycation-sensitive membrane electrode. 
Biosens. Bioelectron., 47, 559–565. 
25. Ye,Y., Wen,W., Xiang,Y., Qi,X., La Belle,J.T., Chen,J.J.L. and Wang,J. (2008) Direct 
Electrochemical Monitoring of RNase Activity. Electroanalysis, 20, 919–922. 
26. Sato,S. and Takenaka,S. (2014) Highly sensitive nuclease assays based on chemically 
modified DNA or RNA. Sensors (Basel)., 14, 12437–50. 
27. Georgiou,C.D., Papapostolou,I. and Grintzalis,K. (2009) Protocol for the quantitative 
assessment of DNA concentration and damage (fragmentation and nicks). Nat. Protoc., 
4, 125–131. 
28. Costa,F., Barbisan,F., Assmann,C.E., Araújo,N.K.F., de Oliveira,A.R., Signori,J.P., 
Rogalski,F., Bonadiman,B., Fernandes,M.S. and da Cruz,I.B.M. (2017) Seminal cell-
free DNA levels measured by PicoGreen fluorochrome are associated with sperm 
fertility criteria. Zygote, 25, 111–119. 
29. Blotta,I., Prestinaci,F., Mirante,S. and Cantafora,A. (2005) Quantitative assay of total 
dsDNA with PicoGreen reagent and real-time fluorescent detection. Ann. Ist. Super. 
Sanita, 41, 119–23. 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/548628doi: bioRxiv preprint first posted online Feb. 13, 2019; 
30. Singer,V.L., Jones,L.J., Yue,S.T. and Haugland,R.P. (1997) Characterization of 
PicoGreen Reagent and Development of a Fluorescence-Based Solution Assay for 
Double-Stranded DNA Quantitation. Anal. Biochem., 249, 228–238. 
31. Choi,S.J. and Szoka,F.C. (2000) Fluorometric determination of deoxyribonuclease I 
activity with PicoGreen. Anal. Biochem., 281, 95–97. 
32. McKnight,R.E., Gleason,A.B., Keyes,J.A. and Sahabi,S. (2007) Binding mode and 
affinity studies of DNA-binding agents using topoisomerase I DNA unwinding assay. 
Bioorg. Med. Chem. Lett., 17, 1013–1017. 
33. Tveit,H. and Kristensen,T. (2001) Fluorescence-based DNA polymerase assay. Anal. 
Biochem., 289, 96–98. 
34. Driscoll,M.D., Rentergent,J. and Hay,S. (2014) A quantitative fluorescence-based 
steady-state assay of DNA polymerase. FEBS J., 281, 2042–50. 
35. Nasiri,H.R., Kiss,L. and Krämer,J. (2016) A fluorescence polarization based assay for 
the identification and characterization of polymerase inhibitors. Bioorg. Med. Chem. 
Lett., 26, 4433–4435. 
36. Gelmini,S., Caldini,A., Becherini,L., Capaccioli,S., Pazzagli,M. and Orlando,C. (1998) 
Rapid, quantitative nonisotopic assay for telomerase activity in human tumors. Clin. 
Chem., 44, 2133–8. 
37. Koepsell,S.A., Hanson,S., Hinrichs,S.H. and Griep,M.A. (2005) Fluorometric assay for 
bacterial primases. Anal. Biochem., 339, 353–355. 
38. Rentergent,J., Driscoll,M.D. and Hay,S. (2016) Time Course Analysis of Enzyme-
Catalyzed DNA Polymerization. Biochemistry, 55, 5622–5634. 
39. Lovett,S.T. (2011) The DNA Exonucleases of Escherichia coli. EcoSal Plus, 4. 
40. Chen,M.-J., Ma,S.-M., Dumitrache,L.C. and Hasty,P. (2007) Biochemical and cellular 
characteristics of the 3’ -&gt; 5’ exonuclease TREX2. Nucleic Acids Res., 35, 2682–
2694. 
41. Ponnaluri,V.K.C., Zhang,G., Estève,P.-O., Spracklin,G., Sian,S., Xu,S., Benoukraf,T. and 
Pradhan,S. (2017) NicE-seq: high resolution open chromatin profiling. Genome Biol., 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/548628doi: bioRxiv preprint first posted online Feb. 13, 2019; 
18, 122. 
42. Grin,I. and Ishchenko,A.A. (2016) An interplay of the base excision repair and mismatch 
repair pathways in active DNA demethylation. Nucleic Acids Res., 44, 3713–27. 
43. Bellaousov,S., Reuter,J.S., Seetin,M.G. and Mathews,D.H. (2013) RNAstructure: web 
servers for RNA secondary structure prediction and analysis. Nucleic Acids Res., 41, 
W471–W474. 
44. Harmon,F.G. and Kowalczykowski,S.C. (1998) RecQ helicase, in concert with RecA and 
SSB proteins, initiates and disrupts DNA recombination. Genes Dev., 12, 1134–44. 
45. Weiss,B. (1976) Endonuclease II of Escherichia coli is Exonuclease III. J. Biol. Chem., 
251, 1896–1901. 
46. Henikoff,S. Ordered deletions for DNA sequencing and in vitro mutagenesis by 
polymerase extension and exonuclease Ill gapping of circular templates. Nucleic Acids 
Res., 18. 
47. Henikoff,S. (1984) Unidirectional digestion with exonuclease III creates targeted 
breakpoints for DNA sequencing. Gene, 28, 351–9. 
48. Ren,B., Zhou,J.-M. and Komiyama,M. (2004) Straightforward detection of SNPs in 
double-stranded DNA by using exonuclease III/nuclease S1/PNA system. Nucleic Acids 
Res., 32, e42. 
49. Tao,C., Yan,Y., Xiang,H., Zhu,D., Cheng,W., Ju,H. and Ding,S. (2015) A new mode for 
highly sensitive and specific detection of DNA based on exonuclease III-assisted target 
recycling amplification and mismatched catalytic hairpin assembly. Chem. Commun. 
(Camb)., 51, 4220–2. 
50. Tubbs,A. and Nussenzweig,A. (2017) Endogenous DNA Damage as a Source of 
Genomic Instability in Cancer. 10.1016/j.cell.2017.01.002. 
51. Hsieh,P. and Zhang,Y. The Devil is in the details for DNA mismatch repair. 
10.1073/pnas.1702747114. 
52. Helleday,T., Lo,J., Vangent,D. and Engelward,B. (2007) DNA double-strand break repair: 
From mechanistic understanding to cancer treatment. DNA Repair (Amst)., 6, 923–935. 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/548628doi: bioRxiv preprint first posted online Feb. 13, 2019; 
53. Krokan,H.E. and Bjørås,M. (2013) Base excision repair. Cold Spring Harb. Perspect. 
Biol., 5, a012583. 
54. Bessho,T., Sancar,A., Thompson,L.H. and Thelen,M.P. (1997) Reconstitution of human 
excision nuclease with recombinant XPF-ERCC1 complex. J. Biol. Chem., 272, 3833–
7. 
55. Franchini,D.-M., Chan,C.-F., Morgan,H., Incorvaia,E., Rangam,G., Dean,W., Santos,F., 
Reik,W. and Petersen-Mahrt,S.K. (2014) Processive DNA Demethylation via DNA 
Deaminase-Induced Lesion Resolution. PLoS One, 9, e97754. 
56. Okano,M., Xie,S. and Li,E. (1998) Cloning and characterization of a family of novel 
mammalian DNA (cytosine-5) methyltransferases. Nat. Genet., 19, 219–220. 
57. Gowher,H. and Jeltsch,A. (2001) Enzymatic properties of recombinant Dnmt3a DNA 
methyltransferase from mouse: the enzyme modifies DNA in a non-processive manner 
and also methylates non-CpA sites. J. Mol. Biol., 309, 1201–1208. 
58. Linxweiler,W. and Hörz,W. (1982) Sequence specificity of exonuclease III from E. coli. 
Nucleic Acids Res., 10, 4845–4859. 
59. Grasby,J.A., Finger,L.D., Tsutakawa,S.E., Atack,J.M. and Tainer,J.A. (2012) Unpairing 
and gating: sequence-independent substrate recognition by FEN superfamily 
nucleases. Trends Biochem. Sci., 37, 74–84. 
60. Shinozaki,K. and Okazaki,T. (1978) T7 gene 6 exonuclease has an RNase H activity. 
Nucleic Acids Res., 5, 4245–61. 
61. Wu,Z.-K., Zhou,D.-M., Wu,Z., Chu,X., Yu,R.-Q. and Jiang,J.-H. (2954) Single-base 
mismatch discrimination by T7 exonuclease with target cyclic amplification detection. 
Chem. Commun. Chem. Commun, 51, 2954–2956. 
62. Uphoff,S., Reyes-Lamothe,R., Garza de Leon,F., Sherratt,D.J. and Kapanidis,A.N. 
(2013) Single-molecule DNA repair in live bacteria. Proc. Natl. Acad. Sci. U. S. A., 110, 
8063–8. 
63. Masamune,Y., Fleischman,R.A. and Richardson,C.C. (1971) Enzymatic Removal and 
Replacement of Nucleotides at Single Strand Breaks in Deoxyribonucleic Acid. J. Biol. 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/548628doi: bioRxiv preprint first posted online Feb. 13, 2019; 
Chem., 246, 2680–2691. 
64. Guan,C. and Kumar,S. (2005) A single catalytic domain of the junction-resolving enzyme 
T7 endonuclease I is a non-specific nicking endonuclease. Nucleic Acids Res., 33, 
6225–34. 
65. Mazur,D.J. and Perrino,F.W. (1999) Identification and expression of the TREX1 and 
TREX2 cDNA sequences encoding mammalian 3’--&gt;5’ exonucleases. J. Biol. Chem., 
274, 19655–60. 
66. Mazur,D.J. and Perrino,F.W. (2001) Excision of 3’ termini by the Trex1 and TREX2 3’--
&gt;5’ exonucleases. Characterization of the recombinant proteins. J. Biol. Chem., 276, 
17022–9. 
67. Takahashi,S., Brazier,J.A. and Sugimoto,N. Topological impact of noncanonical DNA 
structures on Klenow fragment of DNA polymerase. 10.1073/pnas.1704258114. 
68. Pan,C.Q., Ulmer,J.S., Herzka,A. and Lazarus,R.A. (1998) Mutational analysis of human 
DNase I at the DNA binding interface: Implications for DNA recognition, catalysis, and 
metal ion dependence. Prorein Sci., 7, 628–636. 
69. Pan,C.Q. and Lazarus,R.A. (1998) Hyperactivity of human DNase I variants. 
Dependence on the number of positively charged residues and concentration, length, 
and environment of DNA. J. Biol. Chem., 273, 11701–8. 
70. Taylor,A.F. and Weiss,B. (1982) Role of exonuclease III in the base excision repair of 
uracil-containing DNA. J. Bacteriol., 151, 351–7. 
71. Samejima,K. and Earnshaw,W.C. (2005) Trashing the genome: the role of nucleases 
during apoptosis. Nat. Rev. Mol. Cell Biol., 6, 677–688. 
72. Britain,G. (1979) Is the DNA of Virus T7 Methylated ? J. Gen. Virol., 4, 609–613. 
73. Perrino,F.W., Harvey,S., McMillin,S. and Hollis,T. (2005) The human TREX2 3’ → 5’-
exonuclease structure suggests a mechanism for efficient nonprocessive DNA 
catalysis. J. Biol. Chem., 280, 15212–8. 
74. Myler,L.R., Gallardo,I.F., Soniat,M.M., Deshpande,R.A., Gonzalez,X.B., Kim,Y., 
Paull,T.T. and Finkelstein,I.J. (2017) Single-Molecule Imaging Reveals How Mre11-
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/548628doi: bioRxiv preprint first posted online Feb. 13, 2019; 
Rad50-Nbs1 Initiates DNA Break Repair. Mol. Cell, 67, 891–898.e4. 
75. Mitsunobu,H., Zhu,B., Lee,S.-J., Tabor,S. and Richardson,C.C. (2014) Flap 
endonuclease of bacteriophage T7: Possible roles in RNA primer removal, 
recombination and host DNA breakdown. Bacteriophage, 4, e28507. 
76. Kumar,S., Peng,X., Daley,J., Yang,L., Shen,J., Nguyen,N., Bae,G., Niu,H., Peng,Y., 
Hsieh,H.-J., et al. (2017) Inhibition of DNA2 nuclease as a therapeutic strategy 
targeting replication stress in cancer cells. Oncogenesis, 6, e319–e319. 
77. Choi,S.-J. and Szoka,F.C. (2000) Fluorometric Determination of Deoxyribonuclease I 
Activity with PicoGreen. Anal. Biochem., 281, 95–97. 
 
  
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/548628doi: bioRxiv preprint first posted online Feb. 13, 2019; 
Figure Legends: 
Figure 1: Optimisation of the fluorescence signal and assay parameters 
a, Schematic depicting the method by which PG (green) intercalates with dsDNA (blue) to 
emit a fluorescent signal. Digestion of this PG:DNA complex by nucleases (red) disrupts the 
duplex structure and causes a concomitant reduction (grey) in signal that can be measured 
in real-time. b, Calibration curve indicating the fluorescent signal emitted by increasing 
concentrations of 80 bp dsDNA and 13.1 kb plasmid DNA. c, Standard curve composed of 
80, 60, 40 and 20 bp sequences. The point shown at 0 on the x-axis is an 80-nt ssDNA 
oligomer to represent the end product of complete resection. d, DNase I titration on an 80 bp 
dsDNA substrate. Dotted grey lines represent controls containing standard duplexes of 
intermediate sizes. e, Extracted maximum gradient from (d) to determine the reaction rate at 
increasing concentrations of DNase I. f, Maximum rate analysis of resection per nM DNase I 
per second. Error bars represent SEM; n=3 in all cases.  
 
Figure 2: Assay validates inhibitory effect of increasing lengths of a 3’ overhang on 3’-
5’ nuclease, ExoIII 
a, Key to stick and ball illustrations of the substrates. The parallel horizontal lines (=) 
represent the dsDNA substrate, and the coloured-in circle represents the combination of 
both biotin and streptavidin (●). b, Calibration curve depicting the fluorescent signal 
according to increasing concentrations of 80-bp oligomer substrate with one terminal BITEG 
modification and in the presence of 0.02 mg/ml streptavidin. c-e, ExoIII titrations as depicted 
in the figures on 50 nM substrates presenting a blunt terminus (c), 2-nt (d) or 4-nt (e) 3’ 
overhang (multi-coloured cartoons), and negative controls (black cartoons) containing 
BITEG-modified 3’-ends. Results were normalised against their respective negative controls 
(absence of ExoIII) and converted to bp. The grey curve in (e) shows the equivalent reaction 
without an overhang, highlighting the loss of activity with a 4 bp 3’ overhang. f, Rate of 
resection by ExoIII on the blunt (red), 2-nt (orange) and 4-nt (green) 3’ overhangs and the 
negative control with BITEG-treated 3’-ends. Minimal loss of activity is observed with a 2-nt 
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overhang, in contrast to almost complete loss of activity with a 4-nt overhang. g, Comparison 
of ExoIII and DNase I activity on their respective substrates. Error bars represent SEM; n=3 
in all cases.  
 
Figure 3: T7 Exo is inhibited by 20-nt 5’ overhangs  
a, 12 nM T7 Exo-mediated resection on 50 nM substrates presenting a blunt (red), 2- 
(orange), 10- (green) and 20-nt (purple) 5’ overhang with. The negative control was 
synthesised with two 5’-BITEG modifications (blue). Results were normalised against their 
respective negative controls and converted to bp. b, Analysis of the rate of resection on the 
substrates in (a). Error bars represent SEM; n=3 in all cases; **p<0.01, ****p<0.0001. 
 
Figure 4: ExoIII and T7 Exo resect through single-nucleotide mismatches  
a, 5 nM and b, 10 nM ExoIII was added to perfectly matched substrates (*S and S*) and 
substrates containing four T:G or A:C mismatches, (*SC>T and G>AS*, respectively), and the 
resection reaction followed. Standard curve is represented by the grey dotted lines. c, 
Calculated resection rate of ExoIII on the complementary and mismatched substrates based 
on maximum gradients in (a) and (b). d, Time (seconds) until the ExoIII reaction reaches 
completion based on the point at which the reaction plateaus. e, 2 nM, f, 7.5 nM and g, 10 
nM T7 Exo was added to complementary substrates (S* and *S) and substrates containing 
four T:G or A:C mismatches (C>TS* and *SG>A, respectively). Standard curve is represented by 
the grey dotted lines. h, Calculated resection rate of T7 Exo on the complementary and 
mismatched substrates. Error bars represent SEM; n=3 in all cases; *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001. 
 
Figure 5: Increased methylcytosine content delays ExoIII-mediated resection; but 
does not affect the rate of resection of either ExoIII or T7 Exonuclease 
a, 5 nM and b, 10 nM ExoIII  was added to a non-methylated substrate, a substrate 
containing one methylated cytosine, and a substrate containing four methylated cytosines 
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(*S, *S1M and *S4M, respectively). Standard curve is represented by the grey dotted lines. c, 
Time (seconds) until the ExoIII reaction reaches completion on the methylated and 
unmethylated substrates based on the point at which the graphs plateau in (a) and (b). d, 
Calculated resection rate of ExoIII based on maximum gradients in (a) and (b). e, 6 nM and 
f, 12 nM T7 Exo on non-methylated and differentially methylated substrates. Standard curve 
is represented by the grey dotted lines. g, Time (seconds) until the T7 Exo reaction reaches 
completion on the methylated and unmethylated substrates based on point at which the 
graphs plateau in (e) and (f). h, Calculated resection rate of ExoIII. Error bars represent 
SEM; n=3 in all cases; *p<0.05, **p<0.01, ***p<0.001.  
 
Figure 6: ExoIII and T7 Exo preferentially resect from a nick than a gap 
a, Schematic of the dsDNA substrate indicating the preferred nicking sites (yellow) and the 
least favourable nicking sites (red) of Nt.CviPII. b-c, Schematic of the dsDNA substrates 
presenting a nick or gap at either the 3’-end for ExoIII, or the 5’-end for T7 Exo. 
d, ExoIII is active against simulated nicked substrates. 40 nM ExoIII was added to a blocked 
substrate (blue) and related substrates designed with either a nick (red) or a gap (orange) 
towards the 3’ end of one strand, showing similar activity against both modified substrates. 
Standard curve is represented by the grey dotted lines. e, Quantification of the Nt.CviPII 
nickase enzyme activity coupled to ExoIII. Nt.CviPII was added to the blocked substrate, 
either with (purple) or without (green) 40 nM ExoIII. Controls from b) are shown for 
comparison. f, Calculated resection rate of nicked and gapped substrates by ExoIII, 
extracted from the maximum gradient. Addition of the nickase significantly increases the 
resection rate, highlighting that the nickase activity is detected. g, T7 Exo is active against 
simulated nicked substrates. 12 nM T7 Exo was added to substrates with a nick (red) or a 
gap (orange) towards the 5’ end of one strand. Negative control is in blue. Standard curve is 
represented by the grey dotted lines. h, Quantification of the Nt.CviPII enzyme activity 
coupled to T7 Exo. Nt.CviPII was added to the blocked substrate, either with (purple) or 
without (green) 12 nM T7. Negative control is in blue. i, Calculated resection rate of nicked 
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and gapped substrates by T7 Exo, extracted from the maximum gradients in (g) and (h). 
Addition of the nickase significantly increases the resection rate, highlighting that the nickase 
activity is detected. Error bars represent SEM; n=3 in all cases; *p<0.05, ****p<0.0001.  
 
Figure 7: Validation of the assay for alternative enzymes that digest ssDNA and 
generate dsDNA 
a, Mammalian Trex2 digestion of single stranded DNA quantified using the PG assay. 
Single-stranded 60-mer (orange), 40-mer (green) and 20-mer (purple) DNA substrates were 
treated with 100 and 200 nM Trex2. Robust digestion was observed in each case. b, Time 
(seconds) until reaction completion based on the point at which the graphs plateau in (a). c, 
Rate of digestion per nM Trex2. Trex2 degrades DNA at a similar rate irrespective of the 
length of the DNA substrate. d, The polymerase activity of the Klenow fragment polymerase 
determined using the PG assay. Three substrates with a 20-, 40- and 60- and overhang with 
a total 80 bases were incubated with 1 nM Klenow fragment. e, Calculated polymerisation 
rate of the Klenow fragment. A clear preference is shown for longer overhangs. Error bars 
represent SEM; n=3 in all cases; ****p<0.0001. 
 
Figure 8: QI fluorescent-based toolkit reiterates RNase A and RNase H activities 
ssRNA and DNA/RNA hybrids, respectively 
a, Robust digestion of 20- and 40-mer ssRNA by 3.64 x 10-4 nM RNase A. b, Quantification 
of the rate of digestion according to the maximum gradient in (a). c, Robust resection of the 
RNA strand of the 20- and 40-mer RNA:DNA hybrids by 280 nM RNase H. d, Quantification 
of the rate of resection based on the maximum gradient in (c). Error bars represent SEM; 
n=3 in all cases; ***p<0.001. 
 
Table 1: Oligonucleotides and their respective stick and ball illustrations 
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